Overview of the hottest pharmaceutical packaging m

2022-09-21
  • Detail

Overview of the pharmaceutical packaging market (Part 1)

in 2001, MSI in the UK conducted a statistical survey on the pharmaceutical packaging industry in the UK from 1997 to 2001 and predicted the period from 2001 to 2006. The survey showed that the development speed of the pharmaceutical packaging industry in the UK was amazing. From 1997 to 2001, it increased by 41%, with an average annual growth rate of 8.9%. By the end of 2001, the total domestic pharmaceutical packaging value was nearly 400million pounds. The industry with the largest proportion is carton packaging, accounting for 28% of the total pharmaceutical packaging, more than £ 100million. Packaging containers ranked second, accounting for 20%

· the proportion of R & D investment in the pharmaceutical industry in the industry ranks first in the world

· the pharmaceutical packaging industry is developing rapidly

· pay attention to the recycling of pharmaceutical packaging waste

· pay attention to the management and market promotion of pharmaceutical packaging enterprises

1 the British pharmaceutical industry is strong, and the proportion of R & D investment to output ranks first in the world

due to the UK's customary spirit of innovation and the strong support of the government, Compared with the mechanical impact testing machine, the new analyzer has always been in the leading position in the world in terms of science and new product development. Especially in the pharmaceutical industry where Rd plays a decisive role. Among the most widely used antibiotics in the world, five out of every ten are the results of British pharmaceutical research. The Cambridge Molecular Biology Laboratory has won more Nobel prizes than any other laboratory in the world. The UK is one of the first countries to explore connecting academia and industry into mutually beneficial partners. Biotechnology is the fastest growing field. Britain is creating many technologies to cultivate transgenic plant varieties with disease, insect and herbicide resistance. These technologies are also being used to cultivate plants that can produce new disease resistant vaccines on a large scale, and to develop new, improved and biodegradable industrial materials

over the years, the pharmaceutical industry in Britain has always been in the forefront of the world. In 2000, Glaxo Williams and SmithKline billings, the two giants of the British pharmaceutical industry, announced their merger to become the world's largest pharmaceutical group, with a market value of 114 billion pounds (about 184.2 billion dollars). The group after cooperation is called GlaxoSmithKline, which will control about 7.5% of the global pharmaceutical market

pharmaceutical industry, as the most successful industry in Britain, ranks first in the high-tech industry. There are more than 400 production and research companies in the UK, mainly in the southeast and northwest of the UK. There are more than 60000 employees, one third of whom are scientific researchers. In 2001, the investment in scientific research and development (RD) exceeded 3billion pounds, accounting for more than 37% of the scientific research investment of the entire manufacturing industry in the UK

in addition, the British biotechnology industry is also quite strong, ranking first in Europe and second in the world (second only to the United States). There are no application fields that cannot be solved, including medicine, diagnosis, chemical industry, commodities, pesticides, environment, etc. The UK market for biotechnology based products and services is more than £ 15billion. There are 250 biotechnology professional companies in the UK, and more than 400 companies are engaged in related industries. At present, more than 1billion pounds are invested in biotechnology research and development every year. One third of European Biological companies are located in the UK. Laws, patents, consulting are made of long glass fiber roving reinforced compression molded polypropylene compound, management, scientific research and testing, and other professional and supporting services are complete, with tacit cooperation

the investment of UK Rd will promote the R & D level of the whole industry. The huge R D investment in pharmaceutical industry is inseparable from its good return. The gross profit margin of the British pharmaceutical industry is higher than 60%, higher than the international average level, and far higher than other industries in the UK, such as chemical, mechanical and electronic industries

the following is the R D input and R D to output ratio of the pharmaceutical industry in the UK from 1972 to 2001 according to the statistics of the British Pharmaceutical Industry Association. It can be seen from the table that the total R D investment in 2001 was more than 3billion pounds, 2.5 times that in 1991 and 73 times that in 1972. Its input-output ratio increased from 7% in 1972 to 24% in 2001. In the same period of 2001, the average number of other developed countries in the world was less than 10%

growth of pharmaceutical R D investment

year pharmaceutical R D investment pharmaceutical R d

(million pounds) investment ratio (%)

1972 42 7

1985 546 14

1990 1140 17

1991 1239 17

1992 1420 17

1993 1707 21

1994 1918 20

1995 1903 19

1996 2078 20

1997 2251 21

1998 2376 23

1999 2785 23

2000 2843 24

2001 3074 24

2 the British pharmaceutical packaging industry is developing rapidly, Great potential

in 2001, MSI made a statistical survey on the British pharmaceutical packaging industry from 1997 to 2001, and predicted the period from 2001 to 2006. The survey shows that the British pharmaceutical packaging industry has developed at an alarming rate. From 1997 to 2001, it increased by 41%, with an average annual growth rate of 8.9%. By the end of 2001, the total domestic pharmaceutical packaging value was nearly 400million pounds. The industry with the largest proportion is carton packaging, accounting for 28% of the total pharmaceutical packaging, more than £ 100million. Packaging containers ranked second, accounting for 20%. During this period, labels and instructions increased by 51%, with an average annual increase of nearly 11%. (to be continued)

Copyright © 2011 JIN SHI